PL2970378T3 - Chromatografia oddziaływań hydrofobowych białek w warunkach bez soli - Google Patents
Chromatografia oddziaływań hydrofobowych białek w warunkach bez soliInfo
- Publication number
- PL2970378T3 PL2970378T3 PL14765488T PL14765488T PL2970378T3 PL 2970378 T3 PL2970378 T3 PL 2970378T3 PL 14765488 T PL14765488 T PL 14765488T PL 14765488 T PL14765488 T PL 14765488T PL 2970378 T3 PL2970378 T3 PL 2970378T3
- Authority
- PL
- Poland
- Prior art keywords
- hydrophobic interaction
- chromatography under
- salt conditions
- interaction protein
- protein chromatography
- Prior art date
Links
- 238000004587 chromatography analysis Methods 0.000 title 1
- 230000002209 hydrophobic effect Effects 0.000 title 1
- 230000003993 interaction Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361791238P | 2013-03-15 | 2013-03-15 | |
| EP14765488.3A EP2970378B1 (en) | 2013-03-15 | 2014-03-15 | Hydrophobic interaction protein chromatography under no-salt conditions |
| PCT/US2014/029930 WO2014145208A1 (en) | 2013-03-15 | 2014-03-15 | Hydrophobic interaction protein chromatography under no-salt conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2970378T3 true PL2970378T3 (pl) | 2021-12-06 |
Family
ID=51537906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14765488T PL2970378T3 (pl) | 2013-03-15 | 2014-03-15 | Chromatografia oddziaływań hydrofobowych białek w warunkach bez soli |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US9994609B2 (pl) |
| EP (2) | EP2970378B1 (pl) |
| JP (1) | JP6592426B2 (pl) |
| DK (1) | DK2970378T3 (pl) |
| PL (1) | PL2970378T3 (pl) |
| WO (1) | WO2014145208A1 (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10023608B1 (en) | 2013-03-13 | 2018-07-17 | Amgen Inc. | Protein purification methods to remove impurities |
| EP2970378B1 (en) | 2013-03-15 | 2021-05-26 | Biogen MA Inc. | Hydrophobic interaction protein chromatography under no-salt conditions |
| WO2015131978A1 (en) * | 2014-03-04 | 2015-09-11 | Merck Patent Gmbh | Robust antibody purification |
| TW201628649A (zh) | 2014-10-09 | 2016-08-16 | 再生元醫藥公司 | 減少醫藥調配物中微可見顆粒之方法 |
| SG11201900201YA (en) | 2016-08-16 | 2019-02-27 | Regeneron Pharma | Methods for quantitating individual antibodies from a mixture |
| AU2017350807B2 (en) | 2016-10-25 | 2022-07-07 | Regeneron Pharmaceuticals, Inc. | Methods and systems for chromatography data analysis |
| EP4467565A3 (en) | 2016-12-21 | 2025-03-12 | Amgen Inc. | Anti-tnf alpha antibody formulations |
| CN118416215A (zh) | 2017-09-19 | 2024-08-02 | 里珍纳龙药品有限公司 | 减少粒子形成的方法以及由其形成的组合物 |
| TWI853823B (zh) | 2018-07-02 | 2024-09-01 | 美商里珍納龍藥品有限公司 | 自混合物製備多肽之系統及方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5641870A (en) * | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| US7427659B2 (en) * | 2003-10-24 | 2008-09-23 | Amgen Inc. | Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction |
| AU2004315196B2 (en) | 2004-01-30 | 2008-10-02 | Amgen Inc. | Process for purifying proteins |
| BRPI0518216C8 (pt) | 2004-10-21 | 2017-03-21 | Ge Healthcare Bio Sciences Ab | ligante de cromatografia, métodos de preparação de uma matriz de separação, e de separação de um ou mais anticorpos de um ou mais outros compostos em uma amostra líquida, matriz de separação, e, coluna de cromatografia descartável. |
| US7408030B2 (en) * | 2005-01-13 | 2008-08-05 | North Carolina State University | Purification of immunoglobulins using affinity chromatography and peptide ligands |
| CN101384623B (zh) * | 2005-12-22 | 2013-07-24 | 常山凯捷健生物药物研发(河北)有限公司 | 白蛋白与治疗剂的预成型偶联物的制备方法 |
| ES2439490T3 (es) | 2007-01-05 | 2014-01-23 | University Of Zurich | Anticuerpo anti-beta amiloide y usos del mismo |
| EP2114984A2 (en) | 2007-01-17 | 2009-11-11 | Merck Serono S.A. | Process for the purification of fc-containing proteins |
| US20110182809A1 (en) | 2008-07-09 | 2011-07-28 | University Of Zurich | Method of Promoting Neurogenesis |
| AU2009269099B2 (en) | 2008-07-09 | 2016-03-10 | Biogen Ma Inc. | Compositions comprising antibodies to LINGO or fragments thereof |
| US8497358B2 (en) | 2008-12-19 | 2013-07-30 | Takeda Pharmaceutical Company Limited | Antibody purification method |
| WO2011046494A1 (en) | 2009-10-12 | 2011-04-21 | Ge Healthcare Bio-Sciences Ab | Separation matrices |
| RU2603055C2 (ru) | 2009-10-20 | 2016-11-20 | Эббви Инк | Выделение и очистка антител против il-13 с применением аффинной хроматографии с белком а |
| JP5699429B2 (ja) * | 2009-12-18 | 2015-04-08 | 東ソー株式会社 | Fcレセプターの精製方法 |
| WO2012078376A1 (en) | 2010-12-08 | 2012-06-14 | Amgen Inc. | Ion exchange chromatography in the presence of an amino acid |
| MX2013014615A (es) | 2011-06-16 | 2014-02-17 | Dsm Ip Assets Bv | Purificacion de anticuerpos por cromatografia de unidad unica. |
| DK2723379T3 (en) | 2011-06-23 | 2018-10-15 | Biogen Int Neuroscience Gmbh | ANTI-ALPHA SYNUCLEIN BINDING MOLECULES |
| US9150645B2 (en) | 2012-04-20 | 2015-10-06 | Abbvie, Inc. | Cell culture methods to reduce acidic species |
| US9249182B2 (en) * | 2012-05-24 | 2016-02-02 | Abbvie, Inc. | Purification of antibodies using hydrophobic interaction chromatography |
| EP2919902B1 (en) | 2012-11-13 | 2020-01-01 | GE Healthcare BioProcess R&D AB | Multimodal anion exchange matrices |
| EP2970378B1 (en) | 2013-03-15 | 2021-05-26 | Biogen MA Inc. | Hydrophobic interaction protein chromatography under no-salt conditions |
| HK1222871A1 (zh) | 2013-05-13 | 2017-07-14 | Medimmune, Llc | 具有最小单体分离的重组多克隆抗体多聚体的分离 |
| NZ756750A (en) | 2013-09-13 | 2022-05-27 | Genentech Inc | Methods and compositions comprising purified recombinant polypeptides |
| CA2942101A1 (en) * | 2014-03-21 | 2015-09-24 | Abbvie Inc. | Anti-egfr antibodies and antibody drug conjugates |
-
2014
- 2014-03-15 EP EP14765488.3A patent/EP2970378B1/en not_active Revoked
- 2014-03-15 EP EP21174536.9A patent/EP3936515A1/en active Pending
- 2014-03-15 WO PCT/US2014/029930 patent/WO2014145208A1/en not_active Ceased
- 2014-03-15 JP JP2016503283A patent/JP6592426B2/ja active Active
- 2014-03-15 DK DK14765488.3T patent/DK2970378T3/da active
- 2014-03-15 PL PL14765488T patent/PL2970378T3/pl unknown
- 2014-03-15 US US14/775,774 patent/US9994609B2/en active Active
-
2018
- 2018-06-11 US US16/005,642 patent/US11111269B2/en active Active
-
2023
- 2023-06-07 US US18/330,783 patent/US20230391820A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3936515A1 (en) | 2022-01-12 |
| US20160024145A1 (en) | 2016-01-28 |
| JP6592426B2 (ja) | 2019-10-16 |
| EP2970378A4 (en) | 2016-11-16 |
| US20230391820A1 (en) | 2023-12-07 |
| US20190144495A1 (en) | 2019-05-16 |
| EP2970378A1 (en) | 2016-01-20 |
| EP2970378B1 (en) | 2021-05-26 |
| JP2016515529A (ja) | 2016-05-30 |
| DK2970378T3 (da) | 2021-08-23 |
| US11111269B2 (en) | 2021-09-07 |
| WO2014145208A1 (en) | 2014-09-18 |
| US9994609B2 (en) | 2018-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL320900A (en) | Heterodimer proteins | |
| IL262804A (en) | Antibodies to human pac1 | |
| AU356625S (en) | Rollator | |
| SG11201510788XA (en) | Protein a chromatography | |
| PL2970378T3 (pl) | Chromatografia oddziaływań hydrofobowych białek w warunkach bez soli | |
| GB201313905D0 (en) | Fixing | |
| SG11201505198WA (en) | Protein purification methods | |
| IL244588B (en) | fusion protein | |
| AU351558S (en) | Headlamp | |
| PL3007564T3 (pl) | Układ strukturyzowanego tłuszczu | |
| GB2514119B (en) | Rooflight assembly | |
| PL3016977T3 (pl) | Ludzkie przeciwciała anty-IL-32 | |
| GB201308057D0 (en) | Protein | |
| GB201304973D0 (en) | Recombinant protein | |
| GB201302878D0 (en) | Modified igG molecules | |
| GB201313099D0 (en) | Serving tray assembly | |
| SG11201507433QA (en) | Purification of proteins using hydrophobic interaction chromatography | |
| SG10201403600SA (en) | Chromatography column | |
| GB201401955D0 (en) | Protein | |
| GB2529365B (en) | Medical headlamp assembly | |
| EP3042192A4 (en) | Weak affinity chromatography | |
| GB2519395B (en) | Chromatographic interface | |
| GB201404271D0 (en) | Superforwarding processor | |
| GB201302030D0 (en) | Protein | |
| GB201302031D0 (en) | Protein |